Gregory Campbell McDermott, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 7 | 2023 | 808 | 2.640 |
Why?
|
Arthritis, Rheumatoid | 10 | 2023 | 3712 | 2.030 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 | 2022 | 220 | 1.240 |
Why?
|
Bronchiectasis | 2 | 2022 | 128 | 0.940 |
Why?
|
Spondylarthritis | 1 | 2024 | 62 | 0.880 |
Why?
|
Spondylitis, Ankylosing | 1 | 2024 | 156 | 0.840 |
Why?
|
Uveitis | 1 | 2024 | 375 | 0.730 |
Why?
|
Peroxidase | 1 | 2020 | 611 | 0.580 |
Why?
|
Autoantibodies | 2 | 2022 | 2035 | 0.520 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1339 | 0.470 |
Why?
|
Kidney Failure, Chronic | 1 | 2022 | 2538 | 0.350 |
Why?
|
Air Pollution | 1 | 2023 | 2286 | 0.340 |
Why?
|
Air Pollutants | 1 | 2023 | 2817 | 0.330 |
Why?
|
Mucin-5B | 2 | 2023 | 141 | 0.260 |
Why?
|
Dioxygenases | 1 | 2024 | 316 | 0.210 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 441 | 0.180 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2022 | 288 | 0.180 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 292 | 0.180 |
Why?
|
Back Pain | 1 | 2024 | 545 | 0.180 |
Why?
|
Thorax | 1 | 2022 | 547 | 0.170 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 451 | 0.160 |
Why?
|
Demography | 1 | 2022 | 1656 | 0.150 |
Why?
|
Remission Induction | 1 | 2022 | 2386 | 0.140 |
Why?
|
Disease Progression | 3 | 2022 | 13284 | 0.140 |
Why?
|
Risk Factors | 8 | 2023 | 72290 | 0.130 |
Why?
|
Lung Transplantation | 1 | 2023 | 1153 | 0.130 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2015 | 2043 | 0.120 |
Why?
|
Asthma | 2 | 2023 | 6011 | 0.120 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2014 | 31 | 0.120 |
Why?
|
Humans | 25 | 2024 | 744343 | 0.120 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2015 | 337 | 0.120 |
Why?
|
Cell Dedifferentiation | 1 | 2014 | 135 | 0.110 |
Why?
|
Carcinosarcoma | 1 | 2014 | 108 | 0.110 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4803 | 0.110 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 349 | 0.110 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2015 | 450 | 0.100 |
Why?
|
Scalp | 1 | 2014 | 380 | 0.100 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2015 | 484 | 0.100 |
Why?
|
Promoter Regions, Genetic | 1 | 2022 | 5867 | 0.100 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 509 | 0.100 |
Why?
|
Migraine Disorders | 1 | 2023 | 1620 | 0.100 |
Why?
|
Lung | 3 | 2023 | 9856 | 0.090 |
Why?
|
Recurrence | 1 | 2022 | 8340 | 0.090 |
Why?
|
Life Style | 1 | 2022 | 3835 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2015 | 3597 | 0.090 |
Why?
|
Odds Ratio | 1 | 2022 | 9849 | 0.090 |
Why?
|
Prevalence | 2 | 2023 | 15226 | 0.090 |
Why?
|
ras Proteins | 1 | 2014 | 1060 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3047 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 5 | 2023 | 17446 | 0.080 |
Why?
|
Carcinoma, Basal Cell | 1 | 2014 | 545 | 0.080 |
Why?
|
Logistic Models | 1 | 2022 | 13408 | 0.080 |
Why?
|
Case-Control Studies | 2 | 2023 | 21746 | 0.080 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2014 | 851 | 0.080 |
Why?
|
Indoles | 1 | 2015 | 1839 | 0.070 |
Why?
|
Male | 12 | 2023 | 350118 | 0.070 |
Why?
|
Middle Aged | 7 | 2022 | 213383 | 0.070 |
Why?
|
Melanoma | 2 | 2015 | 5510 | 0.070 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2015 | 1265 | 0.070 |
Why?
|
Sulfonamides | 1 | 2015 | 1938 | 0.070 |
Why?
|
Female | 11 | 2023 | 380194 | 0.060 |
Why?
|
Mutation | 4 | 2024 | 29786 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2014 | 5686 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12261 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2014 | 2564 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2866 | 0.060 |
Why?
|
Prognosis | 2 | 2021 | 29063 | 0.050 |
Why?
|
Sarcoma | 1 | 2014 | 1897 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9648 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3444 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4554 | 0.050 |
Why?
|
Prospective Studies | 2 | 2023 | 53288 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39050 | 0.050 |
Why?
|
Vital Capacity | 1 | 2023 | 925 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5172 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2734 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2023 | 77449 | 0.040 |
Why?
|
Respiratory Function Tests | 1 | 2023 | 1616 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2023 | 1475 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4838 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2023 | 1743 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1119 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1381 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7880 | 0.040 |
Why?
|
Phenotype | 3 | 2023 | 16365 | 0.030 |
Why?
|
Tumor Stem Cell Assay | 1 | 2015 | 118 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6773 | 0.030 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2014 | 72 | 0.030 |
Why?
|
Vinculin | 1 | 2014 | 62 | 0.030 |
Why?
|
Desmoplakins | 1 | 2014 | 62 | 0.030 |
Why?
|
Alcohol Oxidoreductases | 1 | 2014 | 170 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8863 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2015 | 677 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2014 | 4851 | 0.030 |
Why?
|
Aged | 7 | 2023 | 163280 | 0.030 |
Why?
|
Biopsy | 2 | 2014 | 6756 | 0.030 |
Why?
|
Alleles | 1 | 2023 | 6933 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11366 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2015 | 850 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2014 | 2256 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1681 | 0.020 |
Why?
|
Genetic Variation | 2 | 2015 | 6544 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1850 | 0.020 |
Why?
|
Genotype | 1 | 2023 | 12951 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2014 | 3701 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1692 | 0.020 |
Why?
|
Protein Conformation | 1 | 2014 | 4011 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3920 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 1941 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2015 | 57776 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 21683 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4204 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4186 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6538 | 0.020 |
Why?
|
DNA Damage | 1 | 2014 | 2432 | 0.020 |
Why?
|
Models, Molecular | 1 | 2014 | 5456 | 0.010 |
Why?
|
Adult | 4 | 2023 | 214055 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13815 | 0.010 |
Why?
|
Child | 2 | 2023 | 77709 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4420 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18111 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2014 | 5021 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14722 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5720 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2015 | 63114 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 41006 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13695 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 56430 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81183 | 0.000 |
Why?
|
Adolescent | 1 | 2015 | 85781 | 0.000 |
Why?
|
Animals | 1 | 2015 | 168757 | 0.000 |
Why?
|